Effect of prior statin therapy on capillary permeability in the lungs after cardiac or vascular surgery

European Respiratory Journal

Volumn 27, Issue 5, 2006, Pages 1026-1032

  van de Visse, E P ^a   van der Heijden, M ^a   Verheij, J ^a   van Nieuw Amerongen, G P ^a   van Hinsbergh, V W M ^a   Girbes, A R J ^a   Groeneveld, A B Johan ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Endothelium; Ischaemia reperfusion; Permeability; Protein permeability

Indexed keywords

ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; GALLIUM 67; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; SIMVASTATIN; TRANSFERRIN;

ACUTE LUNG INJURY; ADULT; AGED; ANEURYSM; ARTICLE; CAPILLARY PERMEABILITY; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE SEVERITY; ELECTIVE SURGERY; FEMALE; HEART INFARCTION; HEART SURGERY; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNIVERSITY HOSPITAL; VASCULAR SURGERY;

ADULT; AGED; CAPILLARY PERMEABILITY; CARDIAC SURGICAL PROCEDURES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LUNG; MIDDLE AGED; PROSPECTIVE STUDIES; VASCULAR SURGICAL PROCEDURES;

EID: 33845472437     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00099405     Document Type: Article

References (30)

1. Milot J, Perron J, Lacasse Y, Letourmeau L, Cartier PC, Maltais F. Incidence and predictors of ARDS after cardiac surgery. Chest 2001; 119: 884-888.
2. 111indium-labelled transferrin and circulating mediators. Thorax 1997; 52: 866-871.
3. Raijmakers PG, Groeneveld AB, Rauwerda JA, et al. Transient increase in interleukin-8 and pulmonary micro-vascular permeability following aortic surgery. Am J Respir Crit Care Med 1995; 151: 698-705.
4. Groeneveld AB. Vascular pharmacology of acute lung injury and acute respiratory distress syndrome. Vascul Pharmacol 2003; 39: 247-256.
5. Asimakopoulos G, Smith PL, Ratnatunga CP, Taylor KM. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg 1999; 68: 1107-1115.
6. 67Ga in the lungs after cardiopulmonary bypass surgery. Chest 1993; 104: 1825-1832.
7. Raijmakers PG, Groeneveld AB, Teule Gf, Thijs LG. Diagnostic value of the gallium-67 pulmonary leak index in pulmonary edema. J Nucl Med 1996; 37: 1316-1322.
8. 67gallium pulmonary leak index in assessing the severity and course of the adult respiratory distress syndrome. Crit Care Med 1996; 24: 1467-1472.
9. van Nieuw Amerongen GP, Vermeer MA, Nègre-Aminou P, Lankelma J, Emeis JJ, van Hinsbergh VW. Simvastatin improves disturbed endothelial barrier function. Circulation 2000; 102: 2803-2809.
10. Wei H, Fang L, Song J, Chatterjee S. Statin-inhibited endothelial permeability could be associated with its effect on PECAM-1 in endothelial cells. FEBS Lett 2005; 579: 1272-1278.
11. Fessler MB, Young SK, Jeyaseelan S, et al. A role for hydroxy-methylglutaryl coenzyme A reductase in pulmonary inflammation and host defense. Am J Respir Crit Care Med 2005; 171: 606-615.
12. Joyce M, Kelly CJ, Chen G, Bouchier-Hayes DJ. Pravastatin attenuates lower torso ischaemia-reperfusion-induced lung injury by upregulating constitutive endothelial nitric oxide synthase. Eur J Vase Endovasc Surg 2001; 21: 295-300.
13. Dell'Omo G, Bandinelli S, Penno G, Pedrinelli R, Mariani M. Simvastatin, capillary permeability, and acetylcholine-mediated vasomotion in atherosclerotic, hypercholesterolemic men. Clin Pharmacol Ther 2000; 68: 427-434.
14. Jacobson JR, Barnard JW, Grigoryev DN, Ma S-F, Tuder RM, Garcia JG. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 2005; 288: L1026-L1032.
15. Naidu BV, Woolley SM, Farivar AS, et al. Early tumor necrosis factor-α release from the pulmonary macrophage in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2004; 127: 1502-1508.
16. Di Napoli P, Antonio Taccardi A, Grilli A, et al. Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts. Cardiovasc Res 2001; 51: 283-293.
17. Naidu BV, Woolley SM, Farivar AS, Thomas R, Fraga. CH, Mulligan MS. Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion. J Thorac Cardiovasc Surg 2003; 126: 482-489.
18. Joyce M, Kelly CJ, Winter DC, Chen G, Leahy A, Bouchier-Hayes DJ. Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion. J Surg Res 2001; 101: 79-84.
19. Jacobson JR, Dudek SM, Birukov KG, et al. Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. Am J Respir Cell Mol Biol 2004; 30: 662-670.
20. Bonetti PO, Wilson SH, Rodriguez-Porcel M, Holmes DR Jr, Lerman LO, Lerman A. Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering. J Am Coll Cardiol 2002; 40: 546-554.
21. Verheij J, Van Lingen A, Raijmakers PG, et al. Effect of fluid loading with saline or colloids on pulmonary permeability, oedema and lung injury score after cardiac and major vascular surgery. Br J Anaesth 2006; 96: 21-30.
22. Anon. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997; 35: 2-3.
23. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001; 91: 1487-1500.
24. Essler M, Amano M, Kruse HJ, Kaibuchi K, Weber PC, Aepfelbacher M. Thrombin inactivatestycosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells. J Biol Chem 1998; 273: 21867-21874.
25. van Hinsbergh VW, van Nieuw Amerongen GP. Intracellular signalling involved in modulating human endothelial barrier function. J Anat 2002; 200: 549-560.
26. van Nieuw Amerongen GP, van Hinsbergh VW. Targets for pharmacological intervention of endothelial hyperper-meability and barrier function. Vascul Pharmacol 2003; 39: 257-272.
27. Wojciak-Stothard B, Ridley AJ. Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol 2003; 39: 187-199.
28. Ohkawara H, Ishibashi T, Sakamoto T, et al. Thrombin-induced rapid geranylgeranylation of RhoA as an essential process for RhoA activation in endothelial cells. J Biol Chem 2001; 280: 10182-10188.
29. Vecchione C, Brandes RP. Withdrawal of 3-hydroxy-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothlial dysfuntion in mice. Circ Res 2002; 91: 173-179.
30. Laufs U, Endres M, Custodis. F, et al. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of Rho GTPase gene transcription. Circulation 2000; 102: 3104-3110.